HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification.

Abstract
Heterotopic ossification (HO) develops in the extremities of wounded service members and is common in the setting of high-energy penetrating injuries and blast-related amputations. No safe and effective prophylaxis modality has been identified for this patient population. Palovarotene has been shown to reduce bone formation in traumatic and genetic models of HO. The purpose of this study was to determine the effects of Palovarotene on inflammation, progenitor cell proliferation, and gene expression following a blast-related amputation in a rodent model (n = 72 animals), as well as the ability of Raman spectroscopy to detect early HO before radiographic changes are present. Treatment with Palovarotene was found to dampen the systemic inflammatory response including the cytokines IL-6 (p = 0.01), TNF-α (p = 0.001), and IFN-γ (p = 0.03) as well as the local inflammatory response via a 76% reduction in the cellular infiltration at post-operative day (POD)-7 (p = 0.03). Palovarotene decreased osteogenic connective tissue progenitor (CTP-O) colonies by as much as 98% both in vitro (p = 0.04) and in vivo (p = 0.01). Palovarotene treated animals exhibited significantly decreased expression of osteo- and chondrogenic genes by POD-7, including BMP4 (p = 0.02). Finally, Raman spectroscopy was able to detect differences between the two groups by POD-1 (p < 0.001). These results indicate that Palovarotene inhibits traumatic HO formation through multiple inter-related mechanisms including anti-inflammatory, anti-proliferative, and gene expression modulation. Further, that Raman spectroscopy is able to detect markers of early HO formation before it becomes radiographically evident, which could facilitate earlier diagnosis and treatment. © 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 36:1135-1144, 2018.
AuthorsBenjamin M Wheatley, Katherine E Cilwa, Devaveena Dey, Ammar T Qureshi, Jonathan G Seavey, Allison M Tomasino, Erin M Sanders, Wesley Bova, Cynthia A Boehm, Masahiro Iwamoto, Benjamin K Potter, Jonathan A Forsberg, George F Muschler, Thomas A Davis
JournalJournal of orthopaedic research : official publication of the Orthopaedic Research Society (J Orthop Res) Vol. 36 Issue 4 Pg. 1135-1144 (04 2018) ISSN: 1554-527X [Electronic] United States
PMID28960501 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Copyright© 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
Chemical References
  • Pyrazoles
  • Stilbenes
  • Palovarotene
Topics
  • Animals
  • Blast Injuries (complications)
  • Cell Proliferation (drug effects)
  • Chondrogenesis (drug effects)
  • Drug Evaluation, Preclinical
  • Gene Expression (drug effects)
  • Male
  • Multipotent Stem Cells (drug effects)
  • Ossification, Heterotopic (etiology, prevention & control)
  • Osteogenesis (drug effects)
  • Pyrazoles (pharmacology, therapeutic use)
  • Rats, Sprague-Dawley
  • Spectrum Analysis, Raman
  • Stilbenes (pharmacology, therapeutic use)
  • Systemic Inflammatory Response Syndrome (prevention & control)
  • War-Related Injuries (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: